MOTS-c vs Retatrutide.
Quick Verdict
MOTS-c is a mitochondrial peptide primarily researched for energy, metabolism, fat loss, longevity, while Retatrutide is a triple agonist (glp-1/gip/glucagon) studied for superior body recomposition, massive fat loss, metabolic health. A key distinction: Retatrutide has FDA approval status.
Side-by-Side Analysis
| Dimension | MOTS-c | Retatrutide |
|---|---|---|
| Category | Mitochondrial Peptide | Triple Agonist (GLP-1/GIP/Glucagon) |
| Mechanism | Regulates mitochondrial function and AMPK. | Multi-receptor activation for appetite suppression, fat oxidation, energy expenditure. |
| Half-Life | ~4 hours | ~6 days |
| Route | SubQ | SubQ |
| Typical Dose | 2000–2000 mcg | 2000–2000 mcg |
| Frequency | 5x/week | 1x/wk |
| Evidence Level | Emerging | Strong |
| Indexed Studies | 20+ indexed | 20+ indexed |
| FDA Status | Research Only | Approved |
| Lowest Price | $39.99 / 10mg via Amino Club | $69.99 / 10mg via Amino Club |
| Per-mg Cost | $4.00/mg | $7.00/mg |
Mechanism of Action Comparison
How MOTS-c Works
MOTS-c MOTS-c is a peptide encoded in mitochondrial DNA studied for improving insulin sensitivity, boosting exercise performance, and protecting against the metabolic decline that comes with aging.
Regulates mitochondrial function and AMPK. Enhances glucose uptake and fatty acid oxidation, improves insulin sensitivity, and protects against age-related metabolic decline.
How Retatrutide Works
Retatrutide Retatrutide is an investigational triple GLP-1/GIP/glucagon receptor agonist studied in Phase 2 trials, producing the highest weight loss ever recorded in an obesity drug trial at 24%.
Multi-receptor activation for appetite suppression, fat oxidation, energy expenditure. Unique triple agonism at GLP-1, GIP, and glucagon receptors delivers synergistic metabolic effects unmatched by single or dual agonists.
Key Mechanistic Difference
MOTS-c operates as a mitochondrial peptide, while Retatrutide functions as a triple agonist (glp-1/gip/glucagon) — these are fundamentally different pharmacological approaches. Retatrutide has a significantly longer half-life (~6 days) compared to MOTS-c (~4 hours), which impacts dosing frequency and sustained activity.
Research Evidence
MOTS-c
20 studies- MOTS-c regulates metabolic homeostasis (Cell Metabolism)Lee et al. (Cell Metabolism): Discovery paper showing MOTS-c is a mitochondrial-derived peptide that regulates insulin s…Emerging
- MOTS-c prevents age-related insulin resistance in miceLee et al.: MOTS-c treatment prevents both age-dependent and high-fat-diet-induced insulin resistance and diet-induced o…Preclinical
- MOTS-c improves skeletal muscle glucose metabolismStudy demonstrating MOTS-c specifically targets skeletal muscle glucose metabolism, providing molecular basis for metabo…Preclinical
Retatrutide
20 studies- Retatrutide Phase 2 trial: ~24% weight loss at 48 weeksJastreboff et al. (NEJM): Phase 2 RCT showing 24.2% body weight reduction at 12mg dose over 48 weeks the highest repor…Strong
- Retatrutide Phase 1 safety and dose-dependent weight lossFirst-in-human Phase 1 trial demonstrating dose-dependent weight loss, favorable safety profile, and significant HbA1c r…Moderate
- Retatrutide reduces liver fat (MASLD Phase 2a sub-study)Randomized Phase 2a sub-study (n=98, Nature Medicine 2024): retatrutide 12mg achieved 82.4% relative liver fat reduction…Strong
Vendor Pricing
· Affiliate links · Prices verified 2026MOTS-c
4 vendorsRetatrutide
1 vendorAffiliate disclosure: PeptiDex may earn a commission from purchases via vendor links at no extra cost to you. See our methodology.
Frequently Asked Questions
Can I take MOTS-c and Retatrutide together?▼
No direct interaction data is available for this specific pair. They target different receptor systems, suggesting they could potentially be combined, but no published protocol validates this combination.
Which has more research evidence — MOTS-c or Retatrutide?▼
MOTS-c has 20 indexed studies (highest evidence: Emerging). Retatrutide has 20 indexed studies (highest evidence: Strong). Both have comparable research coverage.
What is the price difference between MOTS-c and Retatrutide?▼
At current verified vendor prices, MOTS-c starts at $4.00/mg while Retatrutide starts at $7.00/mg. Prices vary by vendor and vial size — see the full vendor comparison below.
Which is better for fat loss — MOTS-c or Retatrutide?▼
Both are researched for fat loss. MOTS-c addresses this via energy, metabolism, fat loss, longevity. Retatrutide approaches it through superior body recomposition, massive fat loss, metabolic health. The optimal choice depends on your specific research protocol and which mechanism aligns with your objectives.
Is MOTS-c or Retatrutide FDA-approved?▼
Retatrutide has FDA approval (or is derived from an FDA-approved compound). MOTS-c is a research compound without FDA approval for human use. FDA status reflects regulatory evaluation — not necessarily superiority for all research applications.
Related Comparisons
Deep Dive Profiles
Shared Research Goals
Research Use Only — Not Medical Advice
This comparison is provided for educational and research purposes only. It does not constitute medical, prescribing, or treatment advice. Clinical data cited here is sourced from published peer-reviewed trials and FDA labels. Consult a qualified healthcare professional before making any decisions about medications or research compounds. PeptiDex is an informational resource and does not sell pharmaceutical products.